PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.69%
Revenue growth 1.25-1.5x META's 6.59%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
8.34%
Gross profit growth above 1.5x META's 4.82%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
6.14%
EBIT growth above 1.5x META's 1.72%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6.14%
Operating income growth above 1.5x META's 1.72%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
8.94%
Positive net income growth while META is negative. John Neff might see a big relative performance advantage.
10.53%
Positive EPS growth while META is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.53%
Positive diluted EPS growth while META is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.29%
Share change of 0.29% while META is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.43%
Diluted share change of 0.43% while META is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
12.25%
OCF growth under 50% of META's 337.98%. Michael Burry might suspect questionable revenue recognition or rising costs.
25.67%
FCF growth under 50% of META's 14400.00%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
5249.83%
10Y CAGR of 5249.83% while META is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
239.29%
5Y CAGR of 239.29% while META is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
70.57%
3Y CAGR of 70.57% while META is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
269.26%
OCF/share CAGR of 269.26% while META is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
75.79%
3Y OCF/share CAGR of 75.79% while META is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
6458.85%
10Y net income/share CAGR of 6458.85% while META is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
249.37%
Net income/share CAGR of 249.37% while META is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
105.72%
3Y net income/share CAGR of 105.72% while META is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
257.56%
Equity/share CAGR of 257.56% while META is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
94.06%
Equity/share CAGR of 94.06% while META is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.31%
AR growth of 0.31% while META is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
40.52%
Inventory growth of 40.52% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
6.52%
Asset growth of 6.52% while META is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
5.16%
BV/share growth of 5.16% while META is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
0.05%
Debt growth of 0.05% while META is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
13.78%
R&D growth drastically higher vs. META's 9.09%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.11%
SG&A growth well above META's 9.50%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.